Correction: Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial

Detalles Bibliográficos
Autores principales: Penson, David F., Armstrong, Andrew J., Concepcion, Raoul S., Agarwal, Neeraj, Olsson, Carl A., Karsh, Lawrence I., Dunshee, Curtis J., Duggan, William, Shen, Qi, Sugg, Jennifer, Haas, Gabriel P., Higano, Celestia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385486/
https://www.ncbi.nlm.nih.gov/pubmed/34848822
http://dx.doi.org/10.1038/s41391-021-00477-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385486/
https://www.ncbi.nlm.nih.gov/pubmed/34848822
http://dx.doi.org/10.1038/s41391-021-00477-3

Ejemplares similares